Depression and Anxiety in People Living With HIV: Why Mental Health Screening Is Critical

How Common Are Depression and Anxiety Among People Living With HIV?

A growing body of research, including a recent cross-sectional study from antiretroviral therapy (ART) centres in Western Rajasthan, India, underscores the substantial mental health burden carried by people living with HIV (PLHIV). According to WHO estimates, depression affects up to 60% of PLHIV globally — far exceeding the roughly 5% prevalence seen in the general adult population. Anxiety disorders and chronic psychological stress are similarly elevated in this population.

The reasons are multifactorial. HIV diagnosis itself can trigger acute psychological distress, compounded by stigma, discrimination, social isolation, and fears about disease progression and mortality. Economic hardship — particularly in low- and middle-income countries where HIV burden is highest — further exacerbates mental health vulnerability. Studies using validated screening tools such as the Depression Anxiety Stress Scales (DASS-21) have consistently documented moderate to severe symptoms across diverse HIV populations in sub-Saharan Africa, South Asia, and Latin America.

How Does Untreated Mental Illness Affect HIV Treatment Outcomes?

The relationship between mental health and HIV treatment adherence is well established. Research published in journals including JAMA Psychiatry and The Lancet HIV has demonstrated that PLHIV with untreated depression are approximately twice as likely to be non-adherent to their antiretroviral medication regimens. Poor adherence leads to incomplete viral suppression, increased risk of drug resistance, higher viral loads, and greater likelihood of onward transmission.

Beyond adherence, psychological distress in PLHIV is associated with faster disease progression, higher rates of opportunistic infections, increased hospitalizations, and elevated mortality. The biological pathways may involve stress-mediated immune dysregulation, including elevated cortisol levels and impaired CD4+ T-cell recovery. WHO guidelines now recommend that mental health assessment be considered a core component of comprehensive HIV care, yet implementation remains inconsistent, particularly in resource-limited settings where the HIV burden is greatest.

What Can Be Done to Improve Mental Health Care for HIV Patients?

Leading health organizations including WHO and UNAIDS advocate for the integration of mental health services directly into HIV care settings. This approach — sometimes called "task-shifting" — trains existing HIV healthcare workers to perform basic mental health screening using tools like the PHQ-9 for depression and GAD-7 for anxiety, with referral pathways for more severe cases. Pilot programmes in countries such as Zimbabwe, Malawi, and South Africa have demonstrated that this model is both feasible and effective.

Evidence-based treatments including cognitive behavioural therapy (CBT), problem-solving therapy, and pharmacotherapy with SSRIs have all shown efficacy in PLHIV populations. Importantly, most commonly prescribed antidepressants have manageable interactions with modern antiretroviral regimens, though clinicians should be aware of potential drug interactions, particularly with protease inhibitors and certain integrase inhibitors. Community-based peer support programmes have also shown promise in reducing stigma and improving both mental health outcomes and ART adherence, offering a scalable solution for low-resource environments.